Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region

NCT01800006 · clinicaltrials.gov ↗

COMPLETED

Status

2101

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)

Sponsor

Bayer

Collaborators

[object Object]